BPC 157 Biosynth Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats BPC 157 has generated significant research attention, but most of it is happening in animal models. Here's what 47 trials and 100+ studies actually reveal: an enormous gap between preclinical promise and human Heard about BPC 157 in health and wellness products? Think it's a "miracle" peptide? Think again. Claims about BPC 157 are based on lab or animal studies, NOT human clinical studies.
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols